Remarkably, pharmacologic inhibition of TREM-1 with the synthetic peptide LP17 abrogated microglial M1 polarization and the activation of pyroptosis-related molecules, improving stroke outcomes [88, 89]. Here, TREM1 is linked to stroke disorder.